Published 8 days ago • loading... • Updated 8 days ago
Marea Therapeutics Presents Phase 1 Data Supporting Potential Best-in-Disease Profile of MAR002 for the Treatment of Acromegaly at ENDO 2026
Summary by Enid News & Eagle
1 Articles
1 Articles
Coverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last Updated100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
